Results 11 to 20 of about 3,290,621 (312)

Malignant Mesothelioma [PDF]

open access: yesCancers, 2021
Malignant mesothelioma (MM) is a rare and aggressive cancer, related to chronic inflammation and oxidative stress caused mainly by exposure to asbestos [...]
Daniel L. Pouliquen, Joanna Kopecka
openaire   +3 more sources

[Therapy of malignant glaucoma]. [PDF]

open access: yes, 2022
Malignant glaucoma is a rare and complex eye disease but the exact cause has not yet been clarified with certainty. Malignant glaucoma can be treated with medication or by means of laser surgery or open incisional surgery.
Häner, N   +4 more
core   +1 more source

LncRNA LTSCCAT promotes tongue squamous cell carcinoma metastasis via targeting the miR-103a-2-5p/SMYD3/TWIST1 axis

open access: yesCell Death and Disease, 2021
Abnormal expression of long-noncoding RNA is involved in the tumorigenesis and progression of various cancers, but the potential molecular regulatory mechanisms are unclear.
Mo Liu   +14 more
doaj   +1 more source

Data: Is it Grey, Maligned or Malignant? [PDF]

open access: yes, 2015
Cancers, growths, past events, social issues, conditions, and trends are each proverbially described as on a spectrum from maligned to malignant and scientists, physicians, journalists, commentators, politicians and other specialists offer opinions and commentary on what frames the answer to this question of the title.
Gelfand, Julia, Tsang, Daniel
openaire   +1 more source

TCRP1 activated by mutant p53 promotes NSCLC proliferation via inhibiting FOXO3a

open access: yesOncogenesis, 2022
Previously, our lab explored that tongue cancer resistance-associated protein (TCRP1) plays a central role in cancer chemo-resistance and progression. Absolutely, TCRP1 was significantly increased in lung cancer. But the mechanism is far from elucidated.
Hao Liu   +8 more
doaj   +1 more source

Clinical evaluation of endolymphatic radiotherapy in malignant lymphoma [PDF]

open access: yes, 1974
By endolymphatic injection of radioisotope 131I.Lipiodol, so.called endolymphatic radiotherapy, we treated 10 cases with malignant lymphoma and found a marked tumor reduction to normal size in all the 10 cases we tried.
Irino, Shozo   +3 more
core   +1 more source

Tumor-associated macrophages promote epithelial–mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling

open access: yesCell Communication and Signaling, 2022
Background Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer with poor prognosis and limited treatment. As a major component of the tumor microenvironment, tumor-associated macrophages (TAMs) play an important role in ...
Xiangzhou Chen   +10 more
doaj   +1 more source

Features Clinical Course and Treatment of Malignant Tumors in Patients with Pulmonary Tuberculosis

open access: yes, 2023
Currently, the combination of tuberculosis and malignant tumors is being detected more and more often. Some believe that tuberculosis and malignant tumors are parallel diseases, others that they are antagonists, others that tuberculosis contributes to ...
Malignant tumor, tuberculosis, lung.
core   +1 more source

Impact of a digital manual for guidance on malignant hyperthermia: patient education

open access: yesOrphanet Journal of Rare Diseases, 2022
Background Malignant hyperthermia (MH) is a rare, hereditary disease with a hypermetabolic response to volatile anesthetics/succinylcholine. Susceptible patients face difficulties due to a lack of knowledge about MH.
Gislene Rodrigues   +4 more
doaj   +1 more source

Targeting nicotinamide N-methyltransferase overcomes resistance to EGFR-TKI in non-small cell lung cancer cells

open access: yesCell Death Discovery, 2022
Activating mutations of epidermal growth factor receptor (EGFR) contributes to the progression of non-small cell lung cancer (NSCLC). EGFR tyrosine kinase inhibitor (TKI)-targeted therapy has become the standard treatment for NSCLC patients with EGFR ...
Jun Wang   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy